Iliac and femoral arterial stents — an overview

References

• Edie J W, Andreasen G F, Zaytoun M. R. Surface corrosion of nitinol and stainless steel under clinical conditions. Angle Ordontodist 1981; 51: 319–24
   PubMed Web of Science ®Google Scholar
• Lucas L, Dale P, Buchanan R., et al. In vitro and in vivo corrosion analyses of implant alloys. 2nd World Congress on Biomaterials 10th Annual Meeting of the Society for Biomaterials. 1984. Vol. LXXX: 84, Series B
   Google Scholar
• Matsumoto A H, Teitelbaum G P, Barth K. H., et al. Tantalum vascular stents: in vivo evaluation with MR imaging. Radiology 1989; 170: 753–5
   Google Scholar
• Oonishi H, Tsuji E, Miyaga M., et al. Biological reaction on Ni in NiTi shape memory alloy. 2nd World Congress on Biomaterials 10th Annual Meeting of the Society for Biomaterials, Washington, DC, 27-May 1 April, 1984, 183
   Google Scholar
• Laissy J P, Grand C, Matos C., et al. Magnetic resonance angiography of intravascular endoprostheses: investigation of three devices. Cardiovasc Intervent Radiol 1995; 18: 360–6
   PubMed Web of Science ®Google Scholar
• Schuermann K, Vorwerk D, Kulisch A., et al. Neointimal hyperplasia in low-profile nitinol stents, Palmaz stents, and Wallstents: a comparative experimental study. Cardiovasc Intervent Radiol 1996; 19: 248–54
   Google Scholar
• Barth K H, Virmani R, Froelich J., et al. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents and Wallstents in canine iliac and femoral arteries. Circulation 1996; 93: 2161–9
   PubMed Web of Science ®Google Scholar
• Sheth S, Litvack F, Dev V., et al. Subacute thrombosis and vascular injury resulting from slotted-tube nitinol and stainless steel stents in a rabbit carotid artery model. Circulation 1996; 94: 1733–40
   PubMed Web of Science ®Google Scholar
• Liermann D. Temporary stenting. Stents — state of the art and future developments, D Liermann. Polyscience Publications Inc., in conjunction with Boston Scientific Corporation Watertown, MA USA, Morin HeightsCanada 1995; 329–38
   Google Scholar
• Strecker E P, Romaniuk P, Schneider B., et al. Perkutan implantierbare, durch Ballon aufdehnbare Gefäß-prothese: Erste klinische Ergebnisse. Dtsch Med Wschr 1988; 113: 538
   Google Scholar
• Strecker E P, Liermann D, Barth K. H., et al. Expandable tubular stents for treatment of arterial occlusive disease: experimental and clinical results. Radiology 1990; 175: 97
   Google Scholar
• Barth K H, Virmani R, Strecker E. P., et al. Flexible tantalum stents implanted in aortas and iliac arteries: effect in normal canines. Radiology 1990; 175: 91–6
   Google Scholar
• Palmaz J C, Laborde J C, Rivera F. J., et al. Stenting of iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Intervent Radiol 1992; 15: 291–7
   PubMed Web of Science ®Google Scholar
• Zollikofer C L, Antonucci F, Pfyffer M., et al. Arterial stent placement with use of the Wallstent: midterm results of clinical experience. Radiology 1991; 179: 449–56
   Google Scholar
• Strecker E-P, Boos I, Hagen B. Flexible tantalum stents for the treatment of iliac artery lesions: long-term patency, complications and risk factors. Radiology 1996; 199: 641–7
   Google Scholar
• Vorwerk D, Guenther R W, Schuermann K., et al. Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients. Radiology 1995; 194: 745–9
   PubMed Web of Science ®Google Scholar
• Henry M, Amor M, Ethevenot G., et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2–4 year follow-up. Radiology 1995; 197: 167–74
   PubMed Web of Science ®Google Scholar
• Strecker E P, Boos I BL, Goettmann D. Femoropopliteal artery stent placement: evaluation of long-term success. Radiology 1997; 205: 375–83
   PubMedGoogle Scholar
• Vroegindeweij D, Vos L D, Tielbeek A. V., et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997; 20: 420–5
   Google Scholar
• Sapoval M R, Long A L, Raynaud A. C., et al. Femoropopliteal stent placement: long-term results. Radiology 1992; 184: 830–9
   Google Scholar
• Tetteroo E, van der Graaf Y, Bosch J. L., et al. for the Dutch Iliac Stent Trial Study Group. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Lancet 1998; 351: 1153–9
   PubMed Web of Science ®Google Scholar
• Bosch J L, Hunink M GM. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement of aortoiliac occlusive disease. Radiology 1997; 204: 87–96
   PubMed Web of Science ®Google Scholar
• van der Giessen W J, Hardhammer P A, van Beusekom H MM, et al. Reduction of thrombotic events using heparin-coated Palmaz-Schatz stents [abstract]. Circulation 1993; 88(Suppl I)1–661
   Google Scholar
• Henry M, Armor M, Ethevenot G., et al. Initial experience with the Cragg Endopro system 1 for intraluminal treatment of peripheral vascular disease. J Endovasc Surg 1994; 1: 31–43
   Google Scholar
• Do D D, Mahler F. Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty. Radiology 1994; 193: 567–71
   Google Scholar
• Strecker E P, Goettmann D, Boos I BL, Vetter S. Low molecular weight heparin (reviparin) reduced the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study. Cardiovasc Intervent Radiol 1998; 21: 375–9
   Google Scholar
• Barragan P, Sainsous J, Silvestri M., et al. Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: prospective study of 1051 consecutive patients. Cathet Cardiovasc Diag 1997; 42: 367–73
   Google Scholar
• Coukell A J, Markham A. Clopidogrel. Drugs 1997; 54: 745–51
   PubMed Web of Science ®Google Scholar
• The EPIC Investigators. Evaluation of c7E3 to prevent ischemic complications. Use of a monoclonal antibody directed against the platelet glycoprotein llb/llla receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956
   PubMed Web of Science ®Google Scholar
• Kereiakes D J, Kleiman N S, Ferguson J. J., et al. for the Oral Glycoprotein llb/llla receptor blockade to inhibit thrombosis (ORBIT) trial investigators. Pharmaco-dynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein llb/llla receptor blockade with oral xemilofiban. Results of a multicenter, placebo-controlled, randomized trial. Circulation 1998; 98: 1268–78
   PubMed Web of Science ®Google Scholar
• Strecker E P, Gabelmann A, Boos I., et al. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc Intervent Radiol 1998; 21: 487–96
   PubMed Web of Science ®Google Scholar
• Hehrlein C, Gollan C, Dönges K, et al. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995; 92: 1570–5
   PubMed Web of Science ®Google Scholar
• Vorwerk D, Guenther R W, Schuermann K., et al. Aortic and iliac stenoses: follow-up results of stent after insufficient balloon angioplasty in 118 cases. Radiology 1996; 198: 45–48
   PubMed Web of Science ®Google Scholar
• Do D D, Triller J, Walpoth B., et al. A comparison study of self-expandable stents vs balloon angioplasty alone in femeropopliteal artery occlusions. Cardiovasc Intervent Radiol 1992; 15: 306–312
   Google Scholar